Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis (Q84595151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Xian-Zong Ye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shi-Cang Yu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Xiu-Wu Bian

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

Journal of Genetics and Genomics

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

423-430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Dynamics of the immune reaction to pancreatic cancer from inception to invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Conne

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Myeloid-derived suppressor cell role in tumor-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Progenitor cells and retinal angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Normal stem cells and cancer stem cells: the niche matters

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Regulatory T cells in the control of immune pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

The role of myeloid cells in the promotion of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Advancements in immune tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Inhibition of tumor growth by elimination of granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Immune escape as a fundamental trait of cancer: focus on IDO.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

L-arginine availability regulates T-lymphocyte cell-cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Altered macrophage differentiation and immune dysfunction in tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

Enrichment of cancer stem cells based on heterogeneity of invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1673-8527%2809%2960061-8

7 January 2021

10.1016/S1673-8527(09)60061-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20659706%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference